Biotech firm Otonomy, listed in the US, has scored its first top-line results from clinical studies of the candidate OTO-413, a potential hearing loss treatment, the company reports in a press release.
In a phase IIa trial that included 30 participants with hearing loss, 20 people received an injection delivering the drug into the inner ear, while the remaining patients received a placebo. Multiple speech-in-noise (SiN) tests were conducted with the participants on day 57 and 85, which included a words-in-noise test where subjects have to distinguish words from background noise, a real-life challenge for those with hearing loss, Otonomy says.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
IRT Manager, Clinical Drug Supply 
2 Sales Representatives and Product Specialists 
Biomarker Operations Lead 
Biostatistician 
Clinical Project Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Senior IT Network Engineer 
Director Global Engineering 
Director for innovative pre-clinical testing unit 
Client Talent Acquisition Specialist 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Project Manager & Scrum Master 
(Senior) Drug Substance Specialist 
Account Manager